These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17601816)

  • 1. Effects of intranasal administration of a leptin-secreting Lactococcus lactis recombinant on food intake, body weight, and immune response of mice.
    Bermúdez-Humarán LG; Nouaille S; Zilberfarb V; Corthier G; Gruss A; Langella P; Issad T
    Appl Environ Microbiol; 2007 Aug; 73(16):5300-7. PubMed ID: 17601816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal co-immunization of mice with recombinant lactococci secreting VapA antigen and leptin elicits a protective immune response against Rhodococcus equi infection.
    Cauchard S; Bermúdez-Humarán LG; Blugeon S; Laugier C; Langella P; Cauchard J
    Vaccine; 2011 Dec; 30(1):95-102. PubMed ID: 22019740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria.
    Cortes-Perez NG; Lefèvre F; Corthier G; Adel-Patient K; Langella P; Bermúdez-Humarán LG
    Vaccine; 2007 Sep; 25(36):6581-8. PubMed ID: 17675182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal immunization with recombinant Lactococcus lactis secreting murine interleukin-12 enhances antigen-specific Th1 cytokine production.
    Bermúdez-Humarán LG; Langella P; Cortes-Perez NG; Gruss A; Tamez-Guerra RS; Oliveira SC; Saucedo-Cardenas O; Montes de Oca-Luna R; Le Loir Y
    Infect Immun; 2003 Apr; 71(4):1887-96. PubMed ID: 12654805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An inducible surface presentation system improves cellular immunity against human papillomavirus type 16 E7 antigen in mice after nasal administration with recombinant lactococci.
    Bermúdez-Humarán LG; Cortes-Perez NG; Le Loir Y; Alcocer-González JM; Tamez-Guerra RS; de Oca-Luna RM; Langella P
    J Med Microbiol; 2004 May; 53(Pt 5):427-433. PubMed ID: 15096553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of fibronectin binding protein A (FnBPA) from Staphylococcus aureus at the cell surface of Lactococcus lactis improves its immunomodulatory properties when used as protein delivery vector.
    Almeida JF; Breyner NM; Mahi M; Ahmed B; Benbouziane B; Boas PC; Miyoshi A; Azevedo V; Langella P; Bermúdez-Humarán LG; Chatel JM
    Vaccine; 2016 Mar; 34(10):1312-8. PubMed ID: 26854905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current prophylactic and therapeutic uses of a recombinant Lactococcus lactis strain secreting biologically active interleukin-12.
    Bermúdez-Humarán LG; Cortes-Perez NG; Ah-Leung S; Lefèvre F; Yang G; Pang Q; Wu C; Zeng Y; Adel-Patient K; Langella P
    J Mol Microbiol Biotechnol; 2008; 14(1-3):80-9. PubMed ID: 17957114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of biologically active CXC chemokines by Lactococcus lactis: evaluation of its potential as a novel mucosal vaccine adjuvant.
    Cortes-Perez NG; da Costa Medina LF; Lefèvre F; Langella P; Bermúdez-Humarán LG
    Vaccine; 2008 Oct; 26(46):5778-83. PubMed ID: 18790708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fusion to a carrier protein and a synthetic propeptide enhances E7 HPV-16 production and secretion in Lactococcus lactis.
    Bermúdez-Humarán LG; Cortes-Perez NG; Le Loir Y; Gruss A; Rodriguez-Padilla C; Saucedo-Cardenas O; Langella P; Montes de Oca-Luna R
    Biotechnol Prog; 2003; 19(3):1101-4. PubMed ID: 12790689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral immunization with recombinant Lactococcus lactis NZ9000 expressing human papillomavirus type 16 E7 antigen and evaluation of its immune effects in female C57BL/6 mice.
    Mohseni AH; Razavilar V; Keyvani H; Razavi MR; Khavari-Nejad RA
    J Med Virol; 2019 Feb; 91(2):296-307. PubMed ID: 30192395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein.
    Foligne B; Dessein R; Marceau M; Poiret S; Chamaillard M; Pot B; Simonet M; Daniel C
    Gastroenterology; 2007 Sep; 133(3):862-74. PubMed ID: 17678918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant porcine epidermal growth factor-secreting Lactococcus lactis promotes the growth performance of early-weaned piglets.
    Wang D; Xu S; Lin Y; Fang Z; Che L; Xue B; Wu D
    BMC Vet Res; 2014 Aug; 10():171. PubMed ID: 25142032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin.
    Huibregtse IL; Snoeck V; de Creus A; Braat H; De Jong EC; Van Deventer SJ; Rottiers P
    Gastroenterology; 2007 Aug; 133(2):517-28. PubMed ID: 17681173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo effects of leptin-related synthetic peptides on body weight and food intake in female ob/ob mice: localization of leptin activity to domains between amino acid residues 106-140.
    Grasso P; Leinung MC; Ingher SP; Lee DW
    Endocrinology; 1997 Apr; 138(4):1413-8. PubMed ID: 9075696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of mucosal and systemic immune responses following oral immunization of mice with Lactococcus lactis expressing human papillomavirus type 16 L1.
    Cho HJ; Shin HJ; Han IK; Jung WW; Kim YB; Sul D; Oh YK
    Vaccine; 2007 Nov; 25(47):8049-57. PubMed ID: 17936447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral administration of an IL-10-secreting Lactococcus lactis strain prevents food-induced IgE sensitization.
    Frossard CP; Steidler L; Eigenmann PA
    J Allergy Clin Immunol; 2007 Apr; 119(4):952-9. PubMed ID: 17316776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variations of N-acetylation level of peptidoglycan do not influence persistence of Lactococcus lactis in the gastrointestinal tract.
    Watterlot L; Meyrand M; Gaide N; Kharrat P; Blugeon S; Gratadoux JJ; Flores MJ; Langella P; Chapot-Chartier MP; Bermúdez-Humarán LG
    Int J Food Microbiol; 2010 Nov; 144(1):29-34. PubMed ID: 20851488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient secretion of a modified E7 protein from human papilloma virus type-16 by Lactococcus lactis.
    Quistián-Martínez D; Villatoro-Hernández J; Loera-Arias MJ; Rangel-Colmenero BR; Zavala-Flores LM; Sepúlveda-Saavedra J; Guzmán-López S; Elizondo-Omaña RE; Montes-de-Oca-Luna R; Saucedo-Cárdenas O
    Lett Appl Microbiol; 2010 Oct; 51(4):383-7. PubMed ID: 20723044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral administration of recombinant Lactococcus lactis expressing bovine beta-lactoglobulin partially prevents mice from sensitization.
    Adel-Patient K; Ah-Leung S; Creminon C; Nouaille S; Chatel JM; Langella P; Wal JM
    Clin Exp Allergy; 2005 Apr; 35(4):539-46. PubMed ID: 15836765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral immunization using live Lactococcus lactis co-expressing LACK and IL-12 protects BALB/c mice against Leishmania major infection.
    Hugentobler F; Di Roberto RB; Gillard J; Cousineau B
    Vaccine; 2012 Aug; 30(39):5726-32. PubMed ID: 22814408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.